We are monitoring the impact of COVID-19 on APAC Epigenetics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1884
Share on
Share on

Asia Pacific Epigenetics Market Research Report – Segmented By Product, KITS, Reagents, Research Area, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1884
Pages: 145

APAC Epigenetics Market Size (2021 to 2026)

The size of the Epigenetics Market in the Asia Pacific is estimated to be worth USD 160.00 million in 2021 and USD 336.05 million by 2026, growing at a CAGR of 16% from 2021 to 2026.

The market for Epigenetics in the APAC region is expected to be driven by the proliferation of chronic diseases such as cancer and increasing awareness regarding the need for epigenetics. Also, the increasing applications of epigenetics in non-oncology diseases are expected to fuel market growth. The other factors, such as decreasing sequencing costs, growing geriatric population, and surge in genome mapping programs, are fuelling the market growth. In addition, increasing preference for personalized medicine and target therapies are more likely to influence the market growth.

On the other hand, the Improving technological advancements in the healthcare sector in emerging countries such as China, India, and Japan contribute to the APAC regional market growth. Key market players are adopting advanced epigenetic procedures and strategic developments, which are predicted to fuel market growth. The major players in the region are conducting research and development activities that are expected to provide lucrative growth opportunities for the market players. 

Furthermore, increasing investments and funding by the government and non-government organizations for the R&D activities and for the development of healthcare infrastructure are encouraging the Epigenetics market.  In addition, the market participants are implementing various strategies such as partnerships between academic, pharmaceutical, and biotechnology companies for epigenetics studies, which are projected to impact market growth positively. 

However, the high cost of instruments and lack of skilled professionals are expected to restrain the market growth. 

This research report on the APAC Epigenetics Market has been segmented & sub-segmented into the following categories:

By Product: 

  • Enzymes
  • Instruments & Consumable
  • KITS
  • Reagents

By Research Area: 

  • Developmental Biology
  • Oncology
  • Drug Delivery

By Enzymes: 

  • DNA-Modifying Enzymes
  • Protein-Modifying Enzymes
  • RNA-Modifying Enzymes

By Instruments & Consumables: 

  • Mass Spectrometers
  • Next-Generation Sequencers
  • qPCR
  • Sonicators

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the APAC is one of the emerging regional markets and is expected to have significant growth rate in the global epigenetics market. The market growth is majorly attributed to the presence of a rapid population, the prevalence of cancer, and improving the healthcare infrastructure. Because of the growing awareness of epigenetics, the expansion of the R&D sector, and the increase in penetration of significant companies in Asia-Pacific, the epigenetics market in Asia-Pacific provides lucrative possibilities for key players. Also, the presence of major market players such as China, India, and Japan are expanding the APAC regional market growth as these countries are significantly investing in R&D to develop new technologies. In addition, en Research Consortium, located in the U.K, has expanded its studies center in Singapore for chronic illness research, including diabetes and obesity.

The Chinese epigenetics market dominated the APAC Epigenetics market during the forecast period due to technological advancements in the healthcare sector and the growing adoption of epigenetics procures. In addition, a large geriatric population and growing demand for epigenetics are projected to increase market growth in the coming years. 

On the other hand, emerging countries such as Japan and India are anticipated to witness a promising share in the APC epigenetics market during the forecast period. Especially the Indian Epigenetics market is likely to expand significantly due to the favorable government incentives, improving healthcare sector, and the growing usage of epigenetics for various applications has led to developments in the market India. Many pharmaceutical firms and research institutions in India spend a significant amount of time establishing modified genes.

KEY MARKET PLAYERS:

Abcam plc., Illumina, Inc., QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif, Diagenode, Inc. and Zymo Research Corporation are some of the prominent companies in the APAC epigenetics market.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Enzymes                  

                                                5.1.2.1 DNA-Modifying Enzymes              

                                                5.1.2.2 Protein-Modifying Enzymes        

                                                5.1.2.3 RNA-Modifying Enzymes              

                                5.1.3 Instruments & Consumables                           

                                                5.1.3.1 Mass Spectrometers       

                                                5.1.3.2 Next-Generation Sequencers     

                                                5.1.3.3 QPCR     

                                                5.1.3.4 Sonicators            

                                                5.1.3.5 Others   

                                5.1.4 KITS                            

                                                5.1.4.1 Bisulfite Conversion KITS               

                                                5.1.4.2 Chip-Sequence KITS        

                                                5.1.4.3 RNA Sequencing KITS     

                                                5.1.4.4 Whole-Genome Amplification KITS          

                                                5.1.4.5 5-HMC and 5-MC Analysis KITS   

                                                5.1.4.6 Others   

                                5.1.5 Reagents                 

                                                5.1.5.1 Antibodies           

                                                5.1.5.2  buffers 

                                                5.1.5.3 Histones               

                                                5.1.5.4 Magnetic Beads

                                                5.1.5.5 Primers

                                                5.1.5.6 Others   

                                5.1.6  Y-o-Y Growth Analysis, By Product                              

                                5.1.7 Market Attractiveness Analysis, By Product                             

                                5.1.8  Market Share Analysis, By Product                              

                5.2 Research Area                                           

                                5.2.1 Introduction                           

                                5.2.2 Developmental Biology                     

                                5.2.3 Oncology                 

                                5.2.4 Drug Delivery                         

                                5.2.5 Y-o-Y Growth Analysis, By Research Area                  

                                5.2.6 Market Attractiveness Analysis, By Research Area                

                                5.2.7 Market Share Analysis, By Research Area                  

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Research Area             

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Research Area             

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Research Area             

                6.2 China                                             

                6.3 India                                              

                6.4 Japan                                            

                6.5 South Korea                                               

                6.6 Australia                                      

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Abcam plc.                                  

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Illumina, Inc.                                              

                8.3 QIAGEN N.V.                                             

                8.4 Merck & Co.                                               

                8.5 New England Biolabs, Inc.                                    

                8.6 Zymo Research Corporation                                

                8.7 Sigma-Aldrich Corporation                                   

                8.8 Thermo Fisher Scientific, Inc.                                              

                8.9 Active Motif                                               

                8.10 Diagenode, Inc.                                      

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Epigenetics Market By Product, From 2021 to 2026 (USD Million)
  2. Asia-Pacific Enzymes Market By Region, From 2021 to 2026 (USD Million)
  3. Asia-Pacific Instruments & Consumables Market By Region, From 2021 to 2026 (USD Million)
  4. Asia-Pacific KITS Market By Region, From 2021 to 2026 (USD Million)
  5. Asia-Pacific Reagents Market By Region, From 2021 to 2026 (USD Million)
  6. Asia-Pacific Epigenetics Market By Research area, From 2021 to 2026 (USD Million)
  7. Asia-Pacific Developmental Biology Market By Region, From 2021 to 2026 (USD Million)
  8. Asia-Pacific Oncology Market By Region, From 2021 to 2026 (USD Million)
  9. Asia-Pacific Drug Delivery Market By Region, From 2021 to 2026 (USD Million)
  10. Japan Epigenetics Market By Product, From 2021 to 2026 (USD Million)
  11. Japan Epigenetics Market By Research area, From 2021 to 2026 (USD Million)
  12. China Epigenetics Market By Product, From 2021 to 2026 (USD Million)
  13. China Epigenetics Market By Research area, From 2021 to 2026 (USD Million)
  14. India Epigenetics Market By Product, From 2021 to 2026 (USD Million)
  15. India Epigenetics Market By Research area, From 2021 to 2026 (USD Million)
  16. Australia Epigenetics Market By Product, From 2021 to 2026 (USD Million)
  17. Australia Epigenetics Market By Research area, From 2021 to 2026 (USD Million)
  18. South Korea Epigenetics Market By Product, From 2021 to 2026 (USD Million)
  19. South Korea Epigenetics Market By Research area, From 2021 to 2026 (USD Million)
  20. Asia-Pacific Epigenetics Market By Enzymes, From 2021 to 2026 (USD Million)
  21. Asia-Pacific DNA-Modifying Enzymes Market By Region, From 2021 to 2026 (USD Million)
  22. Asia-Pacific Protein-Modifying Enzymes Market By Region, From 2021 to 2026 (USD Million)
  23. Asia-Pacific RNA-Modifying Enzymes Market By Region, From 2021 to 2026 (USD Million)
  24. Japan Epigenetics Market By Enzymes, From 2021 to 2026 (USD Million)
  25. China Epigenetics Market By Enzymes, From 2021 to 2026 (USD Million)
  26. India Epigenetics Market By Enzymes, From 2021 to 2026 (USD Million)
  27. Australia Epigenetics Market By Enzymes, From 2021 to 2026 (USD Million)
  28. Asia-Pacific Epigenetics Market By Instruments & Consumables , From 2021 to 2026 (USD Million)
  29. Asia-Pacific Mass Spectrometers Market By Region, From 2021 to 2026 (USD Million)
  30. Asia-Pacific Next-Generation Sequencers Market By Region, From 2021 to 2026 (USD Million)
  31. Asia-Pacific QPCR Market By Region, From 2021 to 2026 (USD Million)
  32. Asia-Pacific Sonicators Market By Region, From 2021 to 2026 (USD Million)
  33. Asia-Pacific Others Market By Region, From 2021 to 2026 (USD Million)
  34. Japan Epigenetics Market By Instruments & Consumables , From 2021 to 2026 (USD Million)
  35. China Epigenetics Market By Instruments & Consumables , From 2021 to 2026 (USD Million)
  36. India Epigenetics Market By Instruments & Consumables , From 2021 to 2026 (USD Million)
  37. Australia Epigenetics Market By Instruments & Consumables , From 2021 to 2026 (USD Million)
  38. Asia-Pacific Epigenetics Market By KITS, From 2021 to 2026 (USD Million)
  39. Asia-Pacific Bisulfite Conversion KITS Market By Region, From 2021 to 2026 (USD Million)
  40. Asia-Pacific Chip-Sequence KITS Market By Region, From 2021 to 2026 (USD Million)
  41. Asia-Pacific RNA Sequencing KITS Market By Region, From 2021 to 2026 (USD Million)
  42. Asia-Pacific Whole-Genome Amplification KITS Market By Region, From 2021 to 2026 (USD Million)
  43. Asia-Pacific 5-HMC and 5-MC Analysis KITS Market By Region, From 2021 to 2026 (USD Million)
  44. Asia-Pacific Others Market By Region, From 2021 to 2026 (USD Million)
  45. Japan Epigenetics Market By KITS, From 2021 to 2026 (USD Million)
  46. China Epigenetics Market By KITS, From 2021 to 2026 (USD Million)
  47. India Epigenetics Market By KITS, From 2021 to 2026 (USD Million)
  48. Australia Epigenetics Market By KITS, From 2021 to 2026 (USD Million)
  49. Asia-Pacific Epigenetics Market By Reagent, From 2021 to 2026 (USD Million)
  50. Asia-Pacific Antibodies Market By Region, From 2021 to 2026 (USD Million)
  51. Asia-Pacific buffers Market By Region, From 2021 to 2026 (USD Million)
  52. Asia-Pacific Histones Market By Region, From 2021 to 2026 (USD Million)
  53. Asia-Pacific Magnetic Beads Market By Region, From 2021 to 2026 (USD Million)
  54. Asia-Pacific Primers  Market By Region, From 2021 to 2026 (USD Million)
  55. Asia-Pacific Others Market By Region, From 2021 to 2026 (USD Million)
  56. Japan Epigenetics Market By Reagent, From 2021 to 2026 (USD Million)
  57. China Epigenetics Market By Reagent, From 2021 to 2026 (USD Million)
  58. India Epigenetics Market By Reagent, From 2021 to 2026 (USD Million)
  59. Australia Epigenetics Market By Reagent, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample